Interleukin-1β rs16944 and rs1143627 polymorphisms and risk of developing major depressive disorder: A case-control study among Bangladeshi population
PLOS ONE · 22.01.2025 · 20 (1) · e0317665
DOI: 10.1371/journal.pone.0317665 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift PLOS ONE, online erschienen am 22.01.2025. Verfasst von Faria Mehreen Toma und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Asia Pacific, Dhaka, Bangladesh. Hauptthemen laut MEDLINE: Interleukin-1beta, Major Depressive Disorder, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Epidemiological research suggests that altered levels of cytokine are associated with pathophysiology and the development of major depressive disorder (MDD). Based on earlier study, IL-1β rs16944 and rs1143627 polymorphisms may increase the risk of depression. Here, we aimed to evaluate the correlation between these polymorphisms and MDD susceptibility among the population in Bangladesh.
Methods
Blood samples were collected from 100 MDD patients and 70 matched controls. Study participants were evaluated by DSM-5 criteria and PCR-RFLP method were applied for genotyping.
Results
The IL1β rs1143627 and rs16944 polymorphisms were found to have a significant association with the risk of MDD. In case of rs1143627 CT heterozygous genotype (OR = 2.22, 95% CI = 1.08–4.55, p-value = 0.029) and combined CT+TT (OR = 2.35, 95% CI = 1.15–4.79, p-value = 0.019) genotype was strongly associated with the increased risk of MDD in comparison to CC common genotype. Moreover, the over-dominant model indicated a 2.15-fold higher risk for MDD development (OR = 2.15, 95% CI = 1.05–4.40, p-value = 0.036). On the other hand, the IL1β rs16944 polymorphisms revealed that the TC+CC combined genotype in the dominant model showed a 2.06-fold increased risk for MDD development compared to the TT common homozygote (OR = 2.06, 95% CI = 1.06–3.99, p-value = 0.032).
Conclusion
Studies suggests that IL1β rs16944 and rs1143627 polymorphisms are associated with an increased risk of MDD. These findings will provide us with valuable insights into the pathophysiology of MDD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, University of Asia Pacific, Dhaka, Bangladesh.
- School of Pharmacy, BRAC University, Dhaka, Bangladesh.
- Department of Pharmacy, Noakhali Science and Technology University, Noakhali, Bangladesh.
ORCID-Profile: Raushanara Akter, Md Rabiul Islam
Zitieren
APA
Toma, F. M., Kalam, K. T., Haque, M. A., Reza, S., Akter, R., Islam, M. S., Islam, M. R., & Nahar, Z. (2025). Interleukin-1β rs16944 and rs1143627 polymorphisms and risk of developing major depressive disorder: A case-control study among Bangladeshi population. PLOS ONE, 20(1), e0317665. https://doi.org/10.1371/journal.pone.0317665
Vancouver
Toma FM, Kalam KT, Haque MA, Reza S, Akter R, Islam MS, et al. Interleukin-1β rs16944 and rs1143627 polymorphisms and risk of developing major depressive disorder: A case-control study among Bangladeshi population. PLOS ONE. 2025;20(1):e0317665. doi:10.1371/journal.pone.0317665
BibTeX
@article{Toma2025,
author = {Toma, Faria Mehreen and Kalam, Khondoker Tashya and Haque, Md Aminul and Reza, Sejuti and Akter, Raushanara and Islam, Mohammad Safiqul and Islam, Md Rabiul and Nahar, Zabun},
title = {Interleukin-1β rs16944 and rs1143627 polymorphisms and risk of developing major depressive disorder: A case-control study among Bangladeshi population},
journal = {PLOS ONE},
year = {2025},
volume = {20},
number = {1},
pages = {e0317665},
doi = {10.1371/journal.pone.0317665}
}
EUVIMED